Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment
Clinical trial NCT03597503 · TERMINATED
Trial details
- NCT number
- NCT03597503
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2020-01-22
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.